This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Thavalakulamgar Sasikumar: Innovator in Pharmaceutical Chemistry
Introduction
Thavalakulamgar Sasikumar is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes involved in metabolic diseases.
Latest Patents
Sasikumar holds a patent for "Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors." This invention focuses on novel tricyclic heterocycles that act as inhibitors of the dipeptidyl peptidase-IV enzyme. These compounds are particularly useful in the treatment or prevention of diseases such as diabetes, especially Type 2 diabetes. The patent also covers pharmaceutical compositions that include these compounds and their applications in treating conditions related to the dipeptidyl peptidase-IV enzyme.
Career Highlights
Sasikumar is associated with Merck Sharp & Dohme Corporation, where he applies his expertise in drug development. His work has contributed to advancements in therapeutic options for patients suffering from diabetes and related metabolic disorders.
Collaborations
Throughout his career, Sasikumar has collaborated with esteemed colleagues, including Duane A Burnett and Zhiqiang Zhao. These partnerships have fostered innovation and enhanced the research efforts in the pharmaceutical domain.
Conclusion
Thavalakulamgar Sasikumar's contributions to pharmaceutical chemistry, particularly through his patent on tricyclic heterocycles, highlight his role as an innovator in the field. His work continues to impact the treatment of diabetes and improve patient outcomes.